Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. (Q43676402)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2001

Language	Label	Description	Also known as
English	Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.	scientific article published in July 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Charlotte G Nyvold

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

K Schmiegelow

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Seyfarth

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Pieters

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M M Rottier

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Knabe

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L P Ryder

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H O Madsen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Svejgaard

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G J Kaspers

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1066-1071

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrupted vs. continued maintenance therapy in childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402144

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402144

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11455975%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43676402&oldid=2206198202"